Loading your workspacePreparing the page and its market data.
Loading the chart…
| Outcome | Chance | 24h | 1 week | Bid · Ask | 24h volume | Ends |
|---|---|---|---|---|---|---|
| Yes | 0% | +4 pts | +2 pts | — · 8¢ | — | ended |
| When | Trader | Outcome | Bet | Size | P&L now | Insider |
|---|---|---|---|---|---|---|
| 531d | Gdub2 fills | Trump confirmed taking Ozempic before July? | BuyNo97¢ → 100¢ | $3,455 | +$107 +3.1% | 4 |
This market will resolve to "Yes" if definitive evidence confirming that Donald Trump is currently or has recently (since January 1, 2024) been using Ozempic, Wegovy, or another GLP-1 receptor agonist primarily prescribed for weight loss or type 2 diabetes, is made public by June 30, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No". Qualifying evidence includes but is not limited to public statements from Trump, a named personal physician, official medical records or other definitive evidence. Unverified or anonymous claims, or documents not substantiated by credible reporting will not qualify. The primary resolution source will be a consensus of credible reporting, and official information from Donald Trump.
Sources: Polymarket's Gamma API, its CLOB price history and its Data API, read every two minutes. Prices are each outcome's Yes price, which is the market's probability: 0¢ for Yes means the market gives it about 0%.